Catalyst Wire Dossier Catalyst Wire Dossier

Sphingomod

fingolimod · Hikma Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sphingomod, covering 2024-08-23 to 2024-08-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt

See pricing